MedPath

Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

Phase 3
Completed
Conditions
Cervical Dystonia
Interventions
Biological: Botulinum toxin type A
Drug: Placebo
Registration Number
NCT00257660
Lead Sponsor
Ipsen
Brief Summary

The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Cervical dystonia with at least 18 months since onset, and previously untreated with botulinum toxin or previously treated with botulinum toxin type A or B with a minimum interval of 16 weeks since the last injection and having returned at least to their usual pre-treatment status
  • TWSTRS severity, disability and total scores meeting the defined criteria at baseline
Exclusion Criteria
  • Pure anterocollis or pure retrocollis
  • In apparent remission from cervical dystonia
  • Previous poor response to the last two botulinum toxin type A or type B treatments
  • Being treated with type B toxin due to lack of efficacy to type A toxin or have known neutralizing antibodies to type A toxin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Botulinum toxin type ADrug: abobotulinumtoxinA (Dysport®)
2PlaceboPlacebo
Primary Outcome Measures
NameTimeMethod
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)Baseline and Week 4

TWSTRS is comprised of three different components which are severity, disability \& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.

Secondary Outcome Measures
NameTimeMethod
Subject VAS for CD Symptom AssessmentBaseline and week 12

The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).

SF-36 Physical Health Summary ScoreWeek 8

SF-36 is a Quality of Life scale comprising eight individual domains. The QoL score for each domain is on a scale from 0 (worst health possible) to 100 (best health possible). SF-36 Physical Health Summary Score is derived from four individual domains (physical functioning, role physical, bodily pain and general health).

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) Total ScoreBaseline and Week 12

TWSTRS is comprised of three different components which are severity, disability \& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.

Subject Visual Analogue Score (VAS) for Cervical Dystonia (CD) Symptom AssessmentBaseline and Week 4

The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).

Investigator VAS for CD Symptom AssessmentBaseline and Week 4

The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms)to 100 mm (worst possible symptoms).

Investigator's VAS for CD Symptom AssessmentBaseline and week 12

The assessment was a continuous 100 mm horizonal line with a scale of 0 mm (no symptoms) to 100 mm (worst possible symptoms).

Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)Baseline and Week 8

TWSTRS is comprised of three different components which are severity, disability \& pain. There is an ordinal scale for each component and the score range for each is the following: for severity from 0 (absence of severity) to 35 (max severity), for disability from 0 (no disability) to 30 (max disability) and for pain from 0 (no pain) to 20 (max pain). TWSTRS total score is the sum of the 3 component scores, with a range from 0 to a maximum of 85. The change in TWSTRS total score is the score at week 4 minus the score at baseline.

SF-36 Mental Health Summary ScoreWeek 8

SF-36 is a Quality of Life scale comprising eight individual domains. The QoL score for each domain is on a scale from 0 (worst health possible) to 100 (best health possible). SF-36 Mental Health Summary Score is derived from four individual domains (vitality, social functioning, role limitations due to emotional problems and mental health).

Number of Participants Considered by the Investigator to be Overall Treatment SuccessesWeek 12

The number of participants considered to be overall treatment successes by the investigator at week 12 was assessed.

Trial Locations

Locations (22)

Parkinson's and Movement Disorder Institute

🇺🇸

Fountain Valley, California, United States

USC School of Medicine

🇺🇸

Los Angeles, California, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

University of Miami

🇺🇸

Miami, Florida, United States

Beth Israel Medical Center

🇺🇸

New York, New York, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

St Petersburg Pavlov State Medical University

🇷🇺

St Petersburg, Russian Federation

Allegeheny General

🇺🇸

Pittsburgh, Pennsylvania, United States

Albany Medical Center

🇺🇸

Albany, New York, United States

Scientific Research Institute of Neurology, RAMS

🇷🇺

Moscow, Russian Federation

Clinic "Cecil Plus"

🇷🇺

Moscow, Russian Federation

Columbia University

🇺🇸

New York, New York, United States

St. Joseph's Hospital and Medical Center

🇺🇸

Phoenix, Arizona, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

University of Iowa

🇺🇸

Iowa City, Iowa, United States

University of Maryland Medical Center

🇺🇸

Baltimore, Maryland, United States

Wayne State University Medical Center

🇺🇸

Southfield, Michigan, United States

University of Texas Southwest

🇺🇸

Dallas, Texas, United States

Municipal Multi-Speciality Hospital #2

🇷🇺

St Petersburg, Russian Federation

Wake Forest University

🇺🇸

Winston-Salem, North Carolina, United States

Swedish Neuroscience

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath